References

References:

  1. Saiki A, Sakamoto K, Bee Y, Izumo T. Nuclear protein of the testis midline carcinoma of the thorax. Jpn J Clin Oncol. 2022;52(6):531-538. https://doi.org/10.1093/jjco/hyac033.
  2. Boland JM. Unusual lung tumors - from morphology to genetics. Mod Pathol. 2022;35(Suppl 1):57-65. https://doi.org/10.1038/s41379-021-00914-7.
  3. Yuan J, Xu Z, Guo Y. Diagnosis, treatment and prognosis of primary pulmonary NUT carcinoma: a literature review. Curr Oncol. 2022;29(10):6807-6815. https://doi.org/10.3390/curroncol29100536.
  4. Zhao D, Cao W, Zha S, Wang Y, Pan Z, Zhang J, Hu K. Primary pulmonary nuclear protein of the testis midline carcinoma: case report and systematic review with pooled analysis. Front Oncol. 2024;13:1308432. https://doi.org/10.3389/fonc.2023.1308432.
  5. Luo W, Stevens TM, Stafford P, Miettinen M, Gatalica Z, Vranic S. NUTM1-rearranged neoplasms - a heterogeneous group of primitive tumors with expanding spectrum of histology and molecular alterations - an updated review. Curr Oncol. 2021;28(6):4485-4503. https://doi.org/10.3390/curroncol28060381.
  6. Jain D, Sauter JL. NUT carcinoma. In: International Academy of Cytology - International Agency for Research on Cancer - World Health Organization Joint Editorial Board. WHO Reporting System for Lung Cytopathology. 1st ed.; vol 1. Lyon (France): International Agency for Research on Cancer; 2022. Available from: https://tumourclassification.iarc.who.int/chapters/48. Accessed November 24, 2024.
  7. Marx A. NUT carcinoma of the thorax. In: WHO Classification of Tumours Editorial Board. Thoracic tumours. 5th ed.; vol 5. Lyon (France): International Agency for Research on Cancer; 2021. Available from: https://tumourclassification.iarc.who.int/chapters/35. Accessed November 24, 2024.
  8. Dutta R, Nambirajan A, Mittal S, Roy-Chowdhuri S, Jain D. Cytomorphology of primary pulmonary NUT carcinoma in different cytology preparations. Cancer Cytopathol. 2021;129:53-61. https://doi.org/10.1002/cncy.22342.